Hope that cannabis oil drug ‘vital’ for seriously ill boy will be made in UK after Brexit threatens supply
Product keeps 11-year-old out of hospital, says mother
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The mother of a seriously ill 11-year-old boy says she has been given fresh hope that a “life-saving" drug hit by Brexit will be produced in the UK.
Supplies of the cannabis oil product, which is produced in Europe and reduces seizures, were hit by Britain leaving the EU single market and customs union.
But Joanne Griffiths said she was buoyed by an announcement from Dutch firm Transvaal Apotheek that it was working with Scottish company Target Healthcare to produce the drug.
Mrs Griffiths, 45, from Preston, Lancashire, said it kept her epileptic son, Ben, out of hospital.
“It’s amazing news, it's fantastic,” she said. “It will be exactly the same product, same method to produce, the same medicine, essentially.”
There were concerns at the turn of the year that Ben's condition would deteriorate after supplies of the cannabis oil shipped in from the Netherlands were halted because there was no agreement between the EU and the UK on importing prescriptions.
She said: “To have the same product made here in the UK is wonderfuland hopefully means people will be able to access it much easier.
“We have obviously been very keen to keep Ben and other children out of hospital, so by keeping Ben on the same product, we think we’ve got a very good chance of that.”
Ben, who has four older sisters and a twin brother, has suffered seizures since birth. He has brain damage, cerebral palsy and autism.
When his condition is at its worst, he has up to 300 seizures a day.
But the cannabis oil he has been on for two years has given him the first seizure-free days of his life. He now typically has no more than five in a day, usually lasting just a few seconds.
Mrs Griffiths said her son's supplies of the oil, which had been due to run out this month, were boosted when the UK government struck a temporary deal with Dutch authorities to supply cannabis oil until July.
Charity Epilepsy Action has been in talks with the government over supplies.
Additional reporting by PA
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments